A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Hexachlorophene
Fluindione
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Fluindione.
Hexachlorophene
Ethyl biscoumacetate
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Ethyl biscoumacetate.
Hexachlorophene
(R)-warfarin
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with (R)-warfarin.
Hexachlorophene
4-hydroxycoumarin
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with 4-hydroxycoumarin.
Hexachlorophene
Acenocoumarol
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Acenocoumarol.
Hexachlorophene
Phenprocoumon
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Phenprocoumon.
Hexachlorophene
Tioclomarol
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Tioclomarol.
Hexachlorophene
Coumarin
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Coumarin.
Hexachlorophene
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorpheniramine.
Hexachlorophene
Hyaluronidase (human recombinant)
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Chlorpheniramine.
Hexachlorophene
Betahistine
The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorpheniramine.
Hexachlorophene
Benzylpenicilloyl polylysine
Chlorpheniramine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
Hexachlorophene
Thalidomide
Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Hexachlorophene
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Chlorpheniramine.
Hexachlorophene
Suvorexant
Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Hexachlorophene
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Chlorpheniramine.
Hexachlorophene
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Chlorpheniramine.
Hexachlorophene
Rotigotine
Chlorpheniramine may increase the sedative activities of Rotigotine.
Hexachlorophene
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Chlorpheniramine.
Hexachlorophene
Paraldehyde
Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3